Treatment of Stage A1 prostate cancer
Finkbeiner, A.E.; Aktinson, W.E.; Haynes, W.D.; Johnston, D.E.; Ross, S.W.
Journal of the Arkansas Medical Society 85(5): 223-224
1988
ISSN/ISBN: 0004-1858 PMID: 2972690 Document Number: 317504
Document emailed within 1 workday
Related Documents
De Voogt, H.J. 1986: Prostate cancer; hormonal treatment in a new stage? Nederlands Tijdschrift Voor Geneeskunde 130(17): 766-768O'Rourke, M.E. 2008: Expectant management as a treatment for early-stage prostate cancer Oncology 22(2 Suppl Nurse Ed): 36-38
Polednak, A.P. 1998: Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status Journal of the National Medical Association 90(2): 101-104
Chiaverini, L.C.; Fulton, J.P.; Buechner, J.S. 2006: Stage at diagnosis and first course of treatment for prostate cancer in Rhode Island, 1990-2003 Medicine and Health Rhode Island 89(2): 81-82
Nikoleishvili, D.; Pertia, A.; Tsintsadze, O.; Gogokhia, N.; Chkhotua, A. 2007: Down-regulation of p27(Kip 1) cyclin-dependent kinase inhibitor in prostate cancer: distinct expression in various prostate cells associating with tumor stage and grades Georgian Medical News 143: 34-38
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Murase, T.; Kuriyama, M.; Maeda, S.; Ando, Y.; Itoh, H.; Watanabe, H. 1996: Prognosis in stage a prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 42(9): 639-643
Feldman-Stewart, D.; Brundage, M.D.; Van Manen, L.; Skarsgard, D.; Siemens, R. 2003: Evaluation of a question-and-answer booklet on early-stage prostate-cancer Patient Education and Counseling 49(2): 115-124
Resnick, M.I.; Grayhack, J.T. 1975: Treatment of stage IV carcinoma of the prostate Urologic Clinics of North America 2(1): 141-161
Horiguchi, A.; Hatakeyama, N.; Ikeuchi, K. 1999: Dynamics of prostate-specific antigen as prognostic factors in endocrine treatment for prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 45(1): 31-35
Peneau, M.; Piéchaud, T.; Cariou, G.; Ragni, E.; Fontaine, E.; Fournier, G. 1998: Clinical stage T3 prostate cancer: natural history, therapeutic choices and their results Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 977-993
Solé Balcells, F.J. 1989: Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A) Archivos Espanoles de Urologia 42(Suppl 2): 131-138
Habib, F.K.; Ross, M.; Bayne, C.W. 1999: Factors controlling the expression of 5alpha-reductase in human prostate: A possible new approach for the treatment of prostate cancer European Urology 35(5-6): 439-442
Nakanishi, S.; Gotou, T.; Sawada, A.; Shibasaki, N.; Ishitoya, T.; Okumura, K. 2009: Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate Hinyokika Kiyo. Acta Urologica Japonica 55(1): 5-8
Kryzhanivs'ka, A.I. 2013: Complications of surgical stage of treatment in patients with cancer of cervix uteri stage IIB Klinichna Khirurhiia 11: 75-78
Vinogradov, V.V.; Klochikhin, A.L. 2010: A new insight into the stage-by-stage combined treatment of T3-4N1-3M0 laryngeal and laryngopharyngeal cancer Vestnik Otorinolaringologii 1: 15-18
Hu, W.L.; Li, Y.Q.; He, H.X.; Li, Q.R.; Tian, Y.; Lai, R.Q.; Mei, H. 2000: KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese Asian Journal of Andrology 2(3): 221-224
Semjonow, A.; Hertle, L. 1995: Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen? Der Urologe. Ausg. a 34(4): 290-296
Jeske, D.R.; Linehan, J.A.; Wilson, T.G.; Kawachi, M.H.; Wittig, K.; Lamparska, K.; Amparo, C.; Mejia, R.; Lai, F.; Georganopoulou, D.; Smith, S.S. 2017: Two-stage classifiers that minimize PCA3 and the PSA proteolytic activity testing in the prediction of prostate cancer recurrence after radical prostatectomy Canadian Journal of Urology 24(6): 9089-9097
Stromberg, J.S.; Martinez, A.A.; Horwitz, E.M.; Gustafson, G.S.; Gonzalez, J.A.; Spencer, W.F.; Brabbins, D.S.; Dmuchowski, C.F.; Hollander, J.B.; Vicini, F.A. 1997: Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment Cancer Journal from Scientific American 3(6): 346-352